New pain pump may cut morphine use after chest surgery
NCT ID NCT01698203
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at a different way to manage pain after chest surgery (thoracotomy) for people who cannot get an epidural. A thin tube placed by the surgeon near the wound delivered either a numbing medicine (ropivacaine) or a saltwater placebo for 48 hours. All participants also received morphine through a patient-controlled pump. The goal was to see if the numbing medicine reduced the total amount of morphine needed. The study included 92 adults and was double-blind, meaning neither patients nor staff knew who got the active drug.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
92 people
The number who actually took part.
- Started
-
Oct 2012
- Finished
-
Oct 2018
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Patients scheduled for thoracotomy who presented with contraindications to TEA. Contraindications to TEA are : * Patient's refusal after informations about advantages and risks of the technique * Anti platelets treatment that can't be discontinued * Anticoagulants at a curative dosage * haemostasis and/or coagulation disorders: thrombopenia \< 100.000/mm3, ACT \> 1,5 / control, PTT \< 75% * Systemic or local infection of the puncture point * 2 and 3 grade atrio-ventricular heart block without pacing * Severe aortic valve stenosis * Kyphoscoliosis * certain neurological disorders Exclusion Criteria: * Patient's refusal to participate in the study * Psychiatric disorder (impossibility to collect the informed consent) * Patient under juridical protection * On going an other study * Pregnancy, breastfeeding * Non balanced epilepsy * 3 grade auriculo-ventricular heart block without pacing * Severe hepatocellular insufficiency * Anti arrhythmic treatment : class III of the Vaughan William's classification * Skin infection of the puncture point * Allergy to aminoamides local anaesthetic * Surgical difficulties to insert paravertebral catheter
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pain are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Civil - NHC Département d'Anesthésiologie
Strasbourg, Alsace, 67091, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a finger sensor reveal whether an epidural is working?
- Five simple signs could help nurses score surgical pain in turkish
- Can green light glasses take the sting out of surgery?
- Can a Hands-On nerve technique ease Fibromyalgia's grip?
- Fixing broken ribs with surgery may cut pain better than drugs alone
- Could a Patient's playlist take the sting out of nerve testing?